Curon Biopharmaceutical (Australia) Co Pty Ltd
3 clinical trials · Sponsor
◉ Watch Curon Biopharmaceutical (Australia) Co Pty Ltd
| Record | Firm | Date |
|---|---|---|
| A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies (NCT04880564) | Curon Biopharmaceutical (Australia) Co Pty Ltd | 2021-07-28 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1 (NCT04418141) | Curon Biopharmaceutical (Australia) Co Pty Ltd | 2020-07-02 |
Track Curon Biopharmaceutical (Australia) Co Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.